Protagenic Therapeutics (PTIX) Competitor Comparison
We are evaluating the key criteria listed to compare Protagenic Therapeutics (PTIX) against its competitors in the Biotechnology industry.
Market Capitalization
365 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
0 / 337Free Cashflow
44 / 352Quick Ratio
212 / 357Earnings per Share
164 / 359Dividend yield
0 / 6Total Cash
336 / 358Performance 3 years
312 / 368Performance 5 years
309 / 368Performance 10 years
280 / 368Linearity 3 years
288 / 368Linearity 5 years
251 / 368Linearity 10 years
228 / 368Total Rank
235 / 368Dividend Rank
245 / 368Valuation Rank
316 / 368Piotroski Rank
304 / 368Muliplier Rank
12 / 368EBITDA - PTIX ranking 0 / 337
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.